Mark Creswell
CAREER SUMMARY
Mark began his career at Warner-Lambert's Ann Arbor, Michigan facility. While working in many therapeutic areas including cardiovascular, antibacterials, oncology, and CNS, Mark held many positions of increasing responsibility. In 1998, Mark accepted the responsibility of building and managing Warner-Lambert's Discovery Chemistry Outsourcing Program. He and his team pioneered the art of managing a successful outsourcing program that brought tremendous value to Warner-Lambert. Following the Pfizer acquisition of Warner-Lambert, Mark was instrumental in forming a centralized global sourcing team. Following the closure of the Pfizer Ann Arbor facility, Mark founded IDSC.
KEY ACCOMPLISHMENTS
- Founder, President, & CEO of IDSC
- 20-Years of Big Pharma experience
- TA experience in cardiovascular, antibacterials, oncology, CNS
- 5-Years combinatorial chemistry experience
- 8-Years discovery chemistry outsourcing experience
- Built and managed Warner-Lambert's and Pfizer/Ann Arbor's discovery outsourcing group
- Managed $19M outsourcing budget
- Built and chaired the global chemistry outsourcing board and globalized the Ann Arbor sourcing model & strategy, expanding the model to seven research sites
PUBLICATIONS
10 patents
12 peer reviewed publications
17 papers presented
AFFILIATIONS
American Chemical Society